Journal rankings · indicator year 2011
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2011
Immunology and Microbiology journal rankings 2011
109 ranked journals · Field in Life Sciences
Immunology and Microbiology has 109 ranked journals in 2011. Its median journal scores above the world average: OJR 1.09 against 1.00, down 0.02 on 2010. A journal needs OJR 1.54 to reach Q1. The top three are Nature Immunology, Immunity, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2011. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2008–2010, the window the 2011 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Immunology and Microbiology (5)
Up to Life Sciences109 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2010. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2008–2010, the window the 2011 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2008–2010 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2002 to 2011. | Compare |
|---|---|---|---|---|---|---|---|
1Nature ImmunologyNature Portfolio · United States | 6.51Q1 | 19.84 1.64 up from 2010 | 651 | 49% | $12,690 | ||
2ImmunityCell Press · United States | 6.02Q1 | 18.72 0.88 down from 2010 | 634 | 100% | $10,400 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 4.43Q1 | 12.37 0.06 up from 2010 | 1,011 | 86% | — | ||
4Annual Review of ImmunologyAnnual Reviews · United States | 3.26Q1 | 67.13 9.15 up from 2010 | 64 | 29% | — | ||
5Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 3.23Q1 | 8.96 1.11 up from 2010 | 1,456 | 52% | $4,900 | ||
6Seminars in ImmunopathologySpringer Science+Business Media · Germany | 3.04Q1 | 7.38 0.21 up from 2010 | 123 | 46% | $3,790 | ||
7Seminars in ImmunologyElsevier BV · United States | 2.77Q1 | 6.59 2.06 down from 2010 | 142 | 41% | $4,370 | ||
8Journal of AutoimmunityElsevier BV · United Kingdom | 2.72Q1 | 9.49 1.77 up from 2010 | 286 | 45% | $5,420 | ||
9The AAPS JournalSpringer Science+Business Media · United States | 2.43Q1 | 5.75 1.64 up from 2010 | 248 | 93% | $5,090 | ||
10Mucosal ImmunologyOAElsevier BV · United States | 2.36Q1 | 6.53 0.39 up from 2010 | 230 | 100% | $4,370 | ||
11The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.19Q1 | 6.56 0.25 up from 2010 | 5,635 | 33% | $3,500 | ||
12International Journal for ParasitologyElsevier BV · Australia | 2.12Q1 | 3.85 0.11 up from 2010 | 486 | 28% | $2,880 | ||
13Infection and ImmunityOAAmerican Society for Microbiology · United States | 2.10Q1 | 4.63 0.10 up from 2010 | 1,839 | 100% | — | ||
14BioDrugsAdis, Springer Healthcare · Switzerland | 2.10Q1 | 4.73 0.58 down from 2010 | 121 | 4% | $5,190 | ||
15Nature reviews. ImmunologyNature Portfolio · United Kingdom | 2.08Q1 | 14.97 0.39 down from 2010 | 596 | 19% | — | ||
16Sexually Transmitted InfectionsBMJ · United Kingdom | 1.89Q1 | 3.29 0.29 down from 2010 | 508 | 86% | — | ||
17Journal of Leukocyte BiologyOxford University Press · United States | 1.84Q1 | 5.46 0.57 up from 2010 | 836 | 36% | $3,800 | ||
18Journal of Innate ImmunityOAKarger Publishers · Switzerland | 1.77Q1 | 4.35 1.71 up from 2010 | 152 | 60% | $3,590 | ||
19European Journal of ImmunologyWiley · Germany | 1.76Q1 | 5.06 0.37 up from 2010 | 1,209 | 72% | $4,550 | ||
20Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 1.72Q1 | 5.06 1.81 up from 2010 | 171 | 17% | $5,490 | ||
21Inflammation & Allergy - Drug TargetsBentham Science Publishers · Netherlands | 1.71Q1 | 4.56 0.91 up from 2010 | 103 | 10% | — | ||
22Molecular and Biochemical ParasitologyElsevier BV · Netherlands | 1.69Q1 | 3.33 0.17 up from 2010 | 385 | 38% | $3,460 | ||
23Genes and ImmunitySpringer Nature · United States | 1.65Q1 | 4.47 0.43 down from 2010 | 270 | 51% | $3,190 | ||
24Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.64Q1 | 4.71 0.65 up from 2010 | 461 | 19% | — | ||
25Critical Reviews in ImmunologyBegell House · United States | 1.64Q1 | 4.59 0.23 up from 2010 | 86 | 17% | — | ||
26Clinical ImmunologyElsevier BV · Netherlands | 1.62Q1 | 4.36 0.27 up from 2010 | 590 | 29% | $4,400 | ||
27Parasites & VectorsOABioMed Central · United Kingdom | 1.57Q1 | 3.37 0.92 up from 2010 | 228 | 100% | $3,090 | ||
28Sexually Transmitted DiseasesLippincott Williams & Wilkins · United States | 1.54Q1 | 2.98 0.17 down from 2010 | 607 | 28% | — | ||
29Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.53Q2 | 3.68 0.04 down from 2010 | 322 | 34% | $4,990 | ||
30BMC ImmunologyOABioMed Central · United Kingdom | 1.47Q2 | 3.43 0.24 down from 2010 | 204 | 100% | $3,090 | ||
31CytokineElsevier BV · United Kingdom | 1.41Q2 | 2.96 0.76 down from 2010 | 588 | 10% | $3,220 | ||
32RetrovirologyOABioMed Central · United Kingdom | 1.41Q2 | 4.57 1.29 up from 2010 | 497 | 100% | $2,890 | ||
33Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.40Q2 | 4.41 0.79 up from 2010 | 719 | 94% | $3,816 | ||
34International ImmunologyOxford University Press · United Kingdom | 1.40Q2 | 3.53 0.31 down from 2010 | 388 | 58% | $3,530 | ||
35Parasite ImmunologyWiley · United Kingdom | 1.37Q2 | 2.85 0.53 up from 2010 | 267 | 26% | $4,220 | ||
36ImmunologyWiley · United Kingdom | 1.37Q2 | 3.64 0.16 up from 2010 | 655 | 67% | $5,330 | ||
37Zoonoses and Public HealthWiley · Germany | 1.32Q2 | 2.35 0.24 up from 2010 | 294 | 20% | $4,880 | ||
38International Reviews of ImmunologyTaylor & Francis · United States | 1.32Q2 | 3.85 0.57 down from 2010 | 75 | 24% | — | ||
39Immunity & AgeingOABioMed Central · United Kingdom | 1.30Q2 | 3.33 0.36 down from 2010 | 52 | 100% | $3,190 | ||
40Immunologic ResearchSpringer Science+Business Media · United States | 1.30Q2 | 2.94 1.01 down from 2010 | 180 | 51% | $2,890 | ||
41Clinical and Developmental ImmunologyOAHindawi Publishing Corporation · United Kingdom | 1.30Q2 | 3.05 0.03 up from 2010 | 62 | 100% | $2,100 | ||
42ImmunobiologyOAElsevier BV · Germany | 1.29Q2 | 3.21 0.63 down from 2010 | 360 | 24% | $2,840 | ||
43Experimental and Applied AcarologySpringer Science+Business Media | 1.27Q2 | 1.91no change | 291 | 13% | $2,390 | ||
44Ticks and Tick-borne DiseasesOAElsevier BV · Germany | 1.27Q2 | 1.79no 2010 value | 42 | 14% | $3,010 | — | |
45Vector-Borne and Zoonotic DiseasesMary Ann Liebert, Inc. · United States | 1.25Q2 | 2.30 0.76 down from 2010 | 449 | 30% | — | ||
46Comparative Immunology Microbiology and Infectious DiseasesElsevier BV · United Kingdom | 1.25Q2 | 1.76 0.57 down from 2010 | 137 | 9% | $3,550 | ||
47Innate ImmunityOASAGE Publishing · United Kingdom | 1.25Q2 | 2.97 0.14 up from 2010 | 158 | 50% | $2,650 | ||
48Experimental ParasitologyElsevier BV · United States | 1.24Q2 | 2.46 0.13 up from 2010 | 660 | 28% | $3,470 | ||
49Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 1.21Q2 | 3.46 1.01 up from 2010 | 309 | 44% | — | ||
50Parasitology ResearchSpringer Science+Business Media · Germany | 1.21Q2 | 2.60 0.19 up from 2010 | 1,370 | 11% | $4,590 |
Subfields of Immunology and Microbiology, compared.
Journals
Citations made in 2011. Corpus-wide, 75.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
32 additional Immunology and Microbiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2008–2010, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2011. Publication window: 2008–2010. How these summaries are calculated
- Ranked journals
- 109
- Window papers (baseline)
- 109,236 +21.5% from indicator year 2008
- Median OJR
- 1.089 +11.4% from indicator year 2008
- Rising journals (2025)
- 12Comparison-group list (12)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2008–2010 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 77 | 81 | 84 | 87 | 84 | 88 | 92 | 96 | 96 | 99 | 100 | 109 | 113 | 118 | 117 | 124 | 126 | 135 | 135 | 131 | 134 | 128 | 131 | 132 | 133 | 130 | |
| Window papers (baseline) | 57,420 | 61,729 | 64,988 | 68,564 | 70,081 | 74,504 | 79,076 | 85,172 | 89,884 | 96,132 | 103,748 | 109,236 | 113,003 | 114,572 | 119,036 | 122,584 | 124,030 | 123,505 | 122,958 | 123,895 | 126,939 | 132,755 | 139,280 | 143,532 | 145,253 | 146,708 | |
| Median OJR | 0.70 | 0.78 | 0.80 | 0.76 | 0.79 | 0.837 | 0.88 | 0.945 | 0.98 | 1.15 | 1.11 | 1.089 | 1.07 | 1.04 | 1.052 | 1.053 | 1.092 | 0.99 | 0.954 | 0.948 | 0.89 | 0.847 | 0.841 | 0.854 | 0.87 | 0.853 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 116 journals |
| Retracted papers per 1,000 | Pooled rate: 1.118 per 1,000 | 102 journals |
| Output growth | Median: -14.5% | 121 journals |
| Open access share | Median: 82.5% | 130 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,340 | 99 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 25.3% | 128 journals |
| Review share | Median: 1.1% | 130 journals |
| Articles-only OJR | Median: 0.85 | 125 journals |
| Uncited share | Median: 25.6% | 130 journals |
| Citation concentration | Median: 42.4% | 130 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.